Visipill builds two connected products for one hard problem: getting the right medication to the right person, and making sure it gets taken. A patented smart appliance for patients at home, and a software platform for the pharmacies that serve them.
A patented, cloud-connected appliance that loads, schedules, and securely dispenses medication by person, and lets every patient see their dose.
Explore the device →
Pharmacy workflow and revenue protection for independent pharmacies. Rule-based automations that run the same way on every prescription, from intake to audit.
Interactive demo. No login, fictitious data. See the live demo →Every other product does part of the job. Visipill is the only one that pairs a bulk-load home device with the pharmacy software that fills and schedules it. No repackaging, no manual data entry, one connected system.
| Capability |  Visipill |
Competitor 1 | Competitor 2 | Competitor 3 | Competitor 4 | Competitor 5 | Competitor 6 | Competitor 7 |
|---|---|---|---|---|---|---|---|---|
| Works with all standard pill sizes | ||||||||
| Bulk load, no pharmacy repackaging | ||||||||
| Pharmacist sets the schedule (no manual entry) | ||||||||
| Touchscreen on the device | ||||||||
| Companion mobile app | ||||||||
| Adherence tracking and caregiver alerts | ||||||||
| Automatic refill replenishment | ||||||||
| Multiple users per device | ||||||||
| Ships its own pharmacy workflow software |
Compiled from vendor-published product information, reviewed against vendor sources in August 2026. Competitors are anonymized and shown for general comparison only; capabilities vary by plan and configuration.
Branding and product design are complete, the device patent is granted, multiple functional prototypes are built, and VisipillRx already has a live interactive demo. A third product, Visipill Inspect, is built and deployed: compliance software for consultant pharmacists, and the first of the Visipill Comply suite. This round takes the device from prototype to pilot production, brings VisipillRx to its first paying pharmacies, and builds the commercial go-to-market.
Series A. Open now to investors, and to strategic partners interested in acquiring or licensing the technology.
Request the deckTake the device to pilot production. Finish design-for-manufacturing and tooling, build a pilot run, and complete FDA registration and listing.
Bring VisipillRx to first revenue. Harden the platform to production and onboard the first paying design-partner pharmacies.
Build the commercial pipeline. Grow design partners across independent and specialty pharmacy.
A pharmacist and consultant of 13+ years across most pharmacy venues. Founded a medication wholesale company, a telemedicine company, and two healthcare-technology companies, with successful exits.
A practicing radiation oncologist of 30+ years. Trained at Memorial Sloan-Kettering, Executive MBA from USF, and an Associate Professor at the USF College of Medicine.
A technologist with 25 years consulting for Fortune 500 firms, a Master's in IT from Illinois Institute of Technology, and recognition across two dozen-plus industry articles.
Whether you want to invest, license the patented technology, or pilot Visipill in your facility, we'd like to hear from you.